Top
Begin typing your search...

Market Live Updates Today: Trends on SGX Nifty indicate a gap-up opening for the index in India with a 125 points gain

Market Live Updates
X
Market Live Updates
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print

The Indian stock market is expected to open in the green as Nifty futures were trading around 15,736 level on the Singaporean Exchange, up 125 points or 0.80 percent.

The BSE Sensex was down 354.89 points at 52,198.51, while the Nifty50 fell 120.30 points to 15,632.10 and formed bearish candle on the daily charts as the closing was lower than opening levels.

According to pivot charts, the key support levels for the Nifty are placed at 15,564.23, followed by 15,496.37. If the index moves up, the key resistance levels to watch out for are 15,714.23 and 15,796.37.

US Markets

The Dow Jones Industrial Average rose 286.01 points, or 0.83%, to 34,798, the S&P 500 gained 35.63 points, or 0.82%, to 4,358.69 and the Nasdaq Composite added 133.08 points, or 0.92%, to 14,631.95.

Asian Markets

Shares in Asia-Pacific were higher in Thursday morning trade, with markets in Japan closed for a holiday. Hong Kong's Hang Seng index was among the biggest gainers regionally, rising 1.19% in early trade. The Taiex in Taiwan also gained 1.01%.

SGX Nifty

Trends on SGX Nifty indicate a gap-up opening for the index in India with a 120 points gain. The Nifty futures were trading at 15,730 on the Singaporean Exchange around 07:30 hours IST.

ADB cuts India's FY22 economic growth forecast to 10%; inflation seen rising marginally to 5.5%

The Asian Development Bank (ADB) has downgraded India's economic growth forecast for the current financial year to 10 percent on Tuesday, from 11 percent projected earlier this year, mainly on account of the adverse impact of the coronavirus pandemic.

"Early indicators show economic activity resuming quickly after containment measures eased. The growth projection for FY2021 (ending March 2022), downgraded from 11 percent in ADO 2021 to 10 percent, reflects large base effects," it said. The ADO was released in April.

Meanwhile, the inflation forecast for Asia and the Pacific this year has been raised to 2.4 percent, from 2.3 percent in April, reflecting rising oil and commodity prices. The projection for 2022 remains at 2.7 percent, it added.

Live Updates

  • 22 July 2021 3:40 AM GMT

    FII and DII data

    Foreign institutional investors (FIIs) net sold shares worth Rs 2,834.96 crore, while domestic institutional investors (DIIs) net purchased shares worth Rs 873.14 crore in the Indian equity market on July 20, as per provisional data available on the NSE.

  • 22 July 2021 3:39 AM GMT

    Anand Rathi Wealth files IPO papers with SEBI

    Anand Rathi Wealth Ltd, part of Mumbai-based financial services group Anand Rathi, has filed preliminary papers with capital markets regulator SEBI to raise funds through an initial share sale. The initial public offer (IPO) is entirely an offer for sale of 1.2 crore equity shares by promoters and existing shareholders, draft red herring prospectus (DRHP)filed with SEBI showed on Tuesday.

    Those offering shares in the offer for sale are -- Anand Rathi Financial Services Limited, Anand Rathi, Pradeep Gupta, Amit Rathi, Priti Gupta, Supriya Rathi, Rawal Family Trust, Jugal Mantri, and Feroze Azee.

  • 22 July 2021 3:39 AM GMT

    Glenmark Life Sciences IPO price band fixed at Rs 695-720, to raise Rs 1,513.6 crore

    Glenmark Life Sciences, the subsidiary of pharma major Glenmark Pharmaceuticals, will open its initial public offering for subscription on July 27. This is the 29th public offering to hit Dalal Street in the current year 2021. The price band for the offer, which will close on July 29, has been fixed at Rs 695-720 per equity share, as per the information available in daily business newspapers. The IPO comprises a fresh issue of Rs 1,060 crore and an offer for sale of 63 lakh equity shares by promoter Glenmark Pharmaceuticals. The fund raising comes to Rs 1,513.6 crore at a higher price band.

    The company will utilise fresh issue proceeds for payment of outstanding purchase consideration to the promoter for the spin-off of the API business from the promoter into the company pursuant to the Business Purchase Agreement dated October 9, 2018 (Rs 800 crore), and funding capital expenditure requirements (Rs 152.76 crore).

  • 22 July 2021 3:38 AM GMT

    SEBI comes out with framework on segregation, monitoring of collateral at client level

    Markets regulator SEBI on Tuesday came out with a framework for segregation and monitoring of collateral at client level amid instances of misuse of client collateral by trading members. Also, it has put in place a reporting mechanism that will entail disaggregated information -- segment-wise and asset type wise break-up -- of each client collateral, according to a circular.

    The measures will help in further strengthening the mechanism of protection of client collateral from misuse by trading member (TM) or clearing member (CM) and default of such members and other clients.

Dwaipayan Bhattacharjee
Next Story
Share it